144 related articles for article (PubMed ID: 7693804)
1. Migration of natural killer cells across endothelial cell monolayers.
Bianchi G; Sironi M; Ghibaudi E; Selvaggini C; Elices M; Allavena P; Mantovani A
J Immunol; 1993 Nov; 151(10):5135-44. PubMed ID: 7693804
[TBL] [Abstract][Full Text] [Related]
2. Regulation of adhesion and transendothelial migration of natural killer cells.
Allavena P; Bianchi G; Paganin C; Giardina G; Mantovani A
Nat Immun; 1996-1997; 15(2-3):107-16. PubMed ID: 9162261
[TBL] [Abstract][Full Text] [Related]
3. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium.
Meerschaert J; Furie MB
J Immunol; 1995 Apr; 154(8):4099-112. PubMed ID: 7535821
[TBL] [Abstract][Full Text] [Related]
4. Role of CD11/CD18 in adhesion and transendothelial migration of T cells. Analysis utilizing CD18-deficient T cell clones.
Kavanaugh AF; Lightfoot E; Lipsky PE; Oppenheimer-Marks N
J Immunol; 1991 Jun; 146(12):4149-56. PubMed ID: 1710241
[TBL] [Abstract][Full Text] [Related]
5. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes.
Oppenheimer-Marks N; Davis LS; Bogue DT; Ramberg J; Lipsky PE
J Immunol; 1991 Nov; 147(9):2913-21. PubMed ID: 1717579
[TBL] [Abstract][Full Text] [Related]
6. Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro.
Meerschaert J; Furie MB
J Immunol; 1994 Feb; 152(4):1915-26. PubMed ID: 7509831
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off.
Greenwood J; Wang Y; Calder VL
Immunology; 1995 Nov; 86(3):408-15. PubMed ID: 8550078
[TBL] [Abstract][Full Text] [Related]
8. Role of LFA-1 and VLA-4 in the adhesion of cloned normal and LFA-1 (CD11/CD18)-deficient T cells to cultured endothelial cells. Indication for a new adhesion pathway.
Vennegoor CJ; van de Wiel-van Kemenade E; Huijbens RJ; Sanchez-Madrid F; Melief CJ; Figdor CG
J Immunol; 1992 Feb; 148(4):1093-101. PubMed ID: 1371131
[TBL] [Abstract][Full Text] [Related]
9. Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1).
Santamaria Babi LF; Moser R; Perez Soler MT; Picker LJ; Blaser K; Hauser C
J Immunol; 1995 Feb; 154(4):1543-50. PubMed ID: 7836740
[TBL] [Abstract][Full Text] [Related]
10. IL-2-activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. Implications for vascular leak syndrome.
Damle NK; Doyle LV
J Immunol; 1989 Apr; 142(8):2660-9. PubMed ID: 2522965
[TBL] [Abstract][Full Text] [Related]
11. Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration.
Chuluyan HE; Osborn L; Lobb R; Issekutz AC
J Immunol; 1995 Sep; 155(6):3135-4. PubMed ID: 7545712
[TBL] [Abstract][Full Text] [Related]
12. Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation.
Berman ME; Xie Y; Muller WA
J Immunol; 1996 Feb; 156(4):1515-24. PubMed ID: 8568255
[TBL] [Abstract][Full Text] [Related]
13. VLA-4 integrin can mediate CD11/CD18-independent transendothelial migration of human monocytes.
Chuluyan HE; Issekutz AC
J Clin Invest; 1993 Dec; 92(6):2768-77. PubMed ID: 7902847
[TBL] [Abstract][Full Text] [Related]
14. Adhesion molecule mechanisms mediating monocyte migration through synovial fibroblast and endothelium barriers: role for CD11/CD18, very late antigen-4 (CD49d/CD29), very late antigen-5 (CD49e/CD29), and vascular cell adhesion molecule-1 (CD106).
Shang XZ; Lang BJ; Issekutz AC
J Immunol; 1998 Jan; 160(1):467-74. PubMed ID: 9552005
[TBL] [Abstract][Full Text] [Related]
15. A three-dimensional model system to study the interactions between human leukocytes and endothelial cells.
Hakkert BC; Rentenaar JM; Van Aken WG; Roos D; Van Mourik JA
Eur J Immunol; 1990 Dec; 20(12):2775-81. PubMed ID: 1980113
[TBL] [Abstract][Full Text] [Related]
16. Migration of recombinant IL-2-activated T and natural killer cells in the intercellular space of human H-2 glioma spheroids in vitro. A study on adhesion molecules involved.
Jääskeläinen J; Mäenpää A; Patarroyo M; Gahmberg CG; Somersalo K; Tarkkanen J; Kallio M; Timonen T
J Immunol; 1992 Jul; 149(1):260-8. PubMed ID: 1351501
[TBL] [Abstract][Full Text] [Related]
17. Molecules involved in the adhesion and cytotoxicity of activated monocytes on endothelial cells.
Jonjic N; Jílek P; Bernasconi S; Peri G; Martìn-Padura I; Cenzuales S; Dejana E; Mantovani A
J Immunol; 1992 Apr; 148(7):2080-3. PubMed ID: 1347549
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.
Thornhill MH; Wellicome SM; Mahiouz DL; Lanchbury JS; Kyan-Aung U; Haskard DO
J Immunol; 1991 Jan; 146(2):592-8. PubMed ID: 1702807
[TBL] [Abstract][Full Text] [Related]
19. Effect of a new monoclonal antibody, TA-2, that inhibits lymphocyte adherence to cytokine stimulated endothelium in the rat.
Issekutz TB; Wykretowicz A
J Immunol; 1991 Jul; 147(1):109-16. PubMed ID: 1711066
[TBL] [Abstract][Full Text] [Related]
20. Involvement of beta 2-integrins in the migration of human natural killer cells.
Somersalo K; Tarkkanen J; Patarroyo M; Saksela E
J Immunol; 1992 Jul; 149(2):590-8. PubMed ID: 1378070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
